NM_000330.4:c.597C>A

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000330.4(RS1):​c.597C>A​(p.Ile199Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000463 in 1,209,755 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 27 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.000047 ( 0 hom. 27 hem. )

Consequence

RS1
NM_000330.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.36

Publications

1 publications found
Variant links:
Genes affected
RS1 (HGNC:10457): (retinoschisin 1) This gene encodes an extracellular protein that plays a crucial role in the cellular organization of the retina. The encoded protein is assembled and secreted from photoreceptors and bipolar cells as a homo-oligomeric protein complex. Mutations in this gene are responsible for X-linked retinoschisis, a common, early-onset macular degeneration in males that results in a splitting of the inner layers of the retina and severe loss in vision. [provided by RefSeq, Oct 2008]
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
CDKL5 Gene-Disease associations (from GenCC):
  • CDKL5 disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • precocious puberty
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant X-18642082-G-T is Benign according to our data. Variant chrX-18642082-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255841.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.36 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 27 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RS1NM_000330.4 linkc.597C>A p.Ile199Ile synonymous_variant Exon 6 of 6 ENST00000379984.4 NP_000321.1
RS1XM_047442337.1 linkc.501C>A p.Ile167Ile synonymous_variant Exon 4 of 4 XP_047298293.1
CDKL5NM_001037343.2 linkc.2714-3925G>T intron_variant Intron 19 of 21 NP_001032420.1
CDKL5NM_003159.3 linkc.2714-3925G>T intron_variant Intron 18 of 20 NP_003150.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RS1ENST00000379984.4 linkc.597C>A p.Ile199Ile synonymous_variant Exon 6 of 6 1 NM_000330.4 ENSP00000369320.3
RS1ENST00000476595.1 linkn.1088C>A non_coding_transcript_exon_variant Exon 5 of 5 1
CDKL5ENST00000379989.6 linkc.2714-3925G>T intron_variant Intron 19 of 21 1 ENSP00000369325.3
CDKL5ENST00000379996.7 linkc.2714-3925G>T intron_variant Intron 18 of 20 1 ENSP00000369332.3

Frequencies

GnomAD3 genomes
AF:
0.0000358
AC:
4
AN:
111727
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000753
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000491
AC:
9
AN:
183138
AF XY:
0.0000591
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000980
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000474
AC:
52
AN:
1098028
Hom.:
0
Cov.:
31
AF XY:
0.0000743
AC XY:
27
AN XY:
363392
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26397
American (AMR)
AF:
0.0000568
AC:
2
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30204
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54142
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40531
Middle Eastern (MID)
AF:
0.000243
AC:
1
AN:
4116
European-Non Finnish (NFE)
AF:
0.0000546
AC:
46
AN:
841961
Other (OTH)
AF:
0.0000434
AC:
2
AN:
46085
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000358
AC:
4
AN:
111727
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
33877
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30690
American (AMR)
AF:
0.00
AC:
0
AN:
10557
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3540
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2678
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6089
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000753
AC:
4
AN:
53098
Other (OTH)
AF:
0.00
AC:
0
AN:
1498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000868
Hom.:
1
Bravo
AF:
0.0000302
EpiCase
AF:
0.00
EpiControl
AF:
0.000296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Apr 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
8.6
DANN
Benign
0.89
PhyloP100
2.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200052722; hg19: chrX-18660202; COSMIC: COSV101183862; COSMIC: COSV101183862; API